Literature DB >> 8000995

Liver, gallbladder, extrahepatic bile ducts, and pancreas.

M T Carriaga1, D E Henson.   

Abstract

BACKGROUND: The liver, gallbladder, bile ducts, and pancreas have a common embryologic origin; cancers that arise from these sites therefore are expected to share a similar spectrum of histologic types. These cancers are known for their extremely poor prognoses.
METHODS: Data from the Surveillance, Epidemiology, and End Results Program regarding the incidence, distribution of histologic types, stage of disease, and survival for cancers of the gallbladder (n = 4412), extrahepatic bile ducts (n = 3486), pancreas (n = 23,116), and liver (n = 6,391) were reviewed. The most common histologic types are discussed, and the frequency of rare types is reported.
RESULTS: The incidence of biliary cancer decreased, while the incidence of hepatic and pancreatic cancer rose slightly over the 15-year period from 1973 to 1987. Age and sex distributions varied by histologic type. Greater than 98% of pancreatic and biliary cancers were carcinomas, and adenocarcinoma (not otherwise specified) was the most common histologic type recorded. In the liver, hepatocellular carcinoma was the most common type, followed by intrahepatic cholangiocarcinoma. The overall 5-year relative survival rates for these cancers were very low: gallbladder, 12.3%; extrahepatic bile duct, 12.7%; liver 3.1%; and pancreas 2.5% (all stages combined, 1978-1986).
CONCLUSIONS: This review confirmed that these carcinomas are associated with a very poor outcome; however, survival was influenced by stage of disease and histologic type. In the gallbladder and extrahepatic bile ducts, papillary adenocarcinoma was associated with the best outcome of all histologic types, and in the exocrine pancreas, mucinous cystadenocarcinoma was associated with the best prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 8000995     DOI: 10.1002/1097-0142(19950101)75:1+<171::aid-cncr2820751306>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  119 in total

Review 1.  Ethnic disparity of pancreatic cancer in New Zealand.

Authors:  Anthony R J Phillips; Carlene M M Lawes; Garth J S Cooper; John A Windsor
Journal:  Int J Gastrointest Cancer       Date:  2002

2.  Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.

Authors:  Wenjun Wang; Zhu-lin Yang; Jie-qiong Liu; Song Jiang; Xiong-ying Miao
Journal:  Tumour Biol       Date:  2011-11-12

Review 3.  Malignant carcinoid tumor of the common bile duct: report of a case.

Authors:  Dong-Hee Kim; Moon-Hee Song; Dong-Hoon Kim
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients.

Authors:  Hua Yang; Guojun Zhai; Xiaoxu Ji; Fuxia Xiong; Jing Su; Michael A McNutt
Journal:  Med Oncol       Date:  2012-12       Impact factor: 3.064

5.  miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.

Authors:  Nataliya Razumilava; Steve F Bronk; Rory L Smoot; Christian D Fingas; Nathan W Werneburg; Lewis R Roberts; Justin L Mott
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

6.  Exfoliative erythroderma as a paraneoplastic presentation of adenocarcinoma of the gallbladder.

Authors:  Sherif Ali Eltawansy; Abhinav Agrawal; Anar Modi; Samaa Hassanien; Bin Zhang; Zhengtong Pei; Wael Ghali
Journal:  J Gastrointest Oncol       Date:  2015-04

7.  Composite large cell neuroendocrine carcinoma and adenocarcinoma of the common bile duct.

Authors:  K Sato; R Waseda; Y Tatsuzawa; H Fujinaga; T Wakabayashi; Y Ueda; S Katsuda
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

8.  Combined adenosquamous and large-cell neuroendocrine carcinoma of the gallbladder.

Authors:  Aurelia Noske; Stefan Pahl
Journal:  Virchows Arch       Date:  2006-03-29       Impact factor: 4.064

9.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

Review 10.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.